Natural Product: NPC141574

Natural Product IDNPC141574
Common Name
?
The InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
6,6'-Methoxygossypol
IUPAC Name 7-(8-formyl-1,7-dihydroxy-6-methoxy-3-methyl-5-propan-2-ylnaphthalen-2-yl)-2,8-dihydroxy-3-methoxy-6-methyl-4-propan-2-ylnaphthalene-1-carbaldehyde
Synonyms
Synthetic Gene Cluster n.a.
ChEMBL Identifier CHEMBL112743
PubChem CID 375713
Chemical Classification
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0000012] Lipids and lipid-like molecules
      • [CHEMONTID:0000259] Prenol lipids
        • [CHEMONTID:0001550] Sesquiterpenoids

The Chemical Classification was calculated by Classyfire, a software for chemical taxonomy calculation. Reference: DOI:10.1186/s13321-016-0174-y.

  Chemical Representations

Standard InCHIKey OUHOXIPLBJIWEG-UHFFFAOYSA-N
Standard InCHI InChI=1S/C32H34O8/c1-13(2)21-17-9-15(5)23(29(37)25(17)19(11-33)27(35)31(21)39-7)24-16(6)10-18-22(14(3)4)32(40-8)28(36)20(12-34)26(18)30(24)38/h9-14,35-38H,1-8H3
SMILES O=Cc1c(O)c(OC)c(c2c1c(O)c(c(c2)C)c1c(C)cc2c(c1O)c(C=O)c(c(c2C(C)C)OC)O)C(C)C

  Calculated Properties

Physi-Chem Properties

Molecular Weight:   546.23 Volume:   566.486
?
Van der Waals volume.
Dense:   0.964 LogP:   4.279
?
The logarithm of the n-octanol/water distribution coefficients.
logD7.4:   3.304
?
The logarithm of the n-octanol/water distribution coefficient at pH=7.4.
LogS:   -4.72
?
The logarithm of aqueous solubility value.
Rotatable Bonds:   7.0 Rigid Bonds:   24.0
TPSA:   133.52
?
Topological Polar Surface Area.
H-Bond Acceptor:   8.0
H-Bond Donor:   4.0 Rings:   4.0
Heavy Atoms:   8.0

MedChem Properties

QED Drug-Likeness Score:   0.182 GASA:   1.0
?
GASA represents the probability of being difficult to synthesize, ranging from 0 to 1.
Synthetic Accessibility Score:   3.592 Fsp3:   0.312
MCE-18:   32.0
?
MCE-18 stands for medicinal chemistry evolution.MCE-18≥45 is considered a suitable value.
Lipinski Rule-of-5:   Rejected
Pfizer Rule:   Rejected GSK Rule:   Accepted
Golden Triangle Rule:   Accepted BMS Rule:   1
Chelating Alert:   1 PAINS Alert:   0
Colloidal aggregators:   0.827 Fluc inhibitor:   0.001
?
The fluc inhibitor value is the probability of being fLuc inhibitors, within the range of 0 to 1.
Blue fluorescence:   0.063
?
The blue fluorescence value is the probability of being blue fluorescence, within the range of 0 to 1
Green fluorescence:   0.541
?
The green fluorescence value is the probability of being green fluorescence, within the range of 0 to 1
Reactive compounds:   0.455 Promiscuous compounds:   0.117

ADMET Properties (ADMETlab3.0)

ADMET: Absorption

Caco-2 Permeability:   -5.273 MDCK Permeability:   -4.836
Pgp-inhibitor:   0.946 Pgp-substrate:   0.0
PAMPA:   0.0
?
The experimental data for Peff was logarithmically transformed (logPeff). Molecules with log Peff values below 2.0 were classified as low-permeability (Category 0), while those with log Peff values exceeding 2.5 were classified as high-permeability (Category 1).
Human Intestinal Absorption (HIA):   0.001
20% Bioavailability (F20%):   0.061 30% Bioavailability (F30%):   0.908
50% Bioavailability (F50%):   0.999

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):   0.063 MRP1:   1.0
Plasma Protein Binding (PPB):   98.556% Volume Distribution (VD):   0.066
Fu: 0.651%
?
The fraction unbound in plasms.
OATP1B1 inhibitor:   0.999
OATP1B3 inhibitor:   0.933 BCRP inhibitor:   0.147
BSEP inhibitor:   1.0

ADMET: Metabolism

CYP1A2-inhibitor:   1.0 CYP1A2-substrate:   0.653
CYP2C19-inhibitor:   0.998 CYP2C19-substrate:   0.974
CYP2C9-inhibitor:   0.441 CYP2C9-substrate:   0.0
CYP2D6-inhibitor:   0.002 CYP2D6-substrate:   0.001
CYP3A4-inhibitor:   1.0 CYP3A4-substrate:   0.999
CYP2B6-substrate:   0.934 CYP2C8-inhibitor:   1.0
HLM stability:   0.937
?
Human liver microsomal (HLM) stability. Category 0: stable+ (HLM > 30 min); Category 1: unstable- (HLM ≤ 30 min). The output value is the probability of human liver microsomal instability, where a value closer to 1 indicates a higher likelihood of instability.

ADMET: Excretion

Clearance (CL):  5.151 Half-life (T1/2):  1.447

ADMET: Toxicity

hERG Blockers:  0.085 hERG Blockers (10um):  0.556
Human Hepatotoxicity (H-HT):  0.613 Drug-induced Liver Injury (DILI):  0.798
AMES Toxicity:  0.268 Rat Oral Acute Toxicity:  0.541
Maximum Recommended Daily Dose:  0.839 Skin Sensitization:  0.614
Carcinogencity:  0.647 Eye Corrosion:  0.002
Eye Irritation:  0.791 Respiratory Toxicity:  0.97
Drug-induced Neurotoxicity:  0.443 Ototoxicity:  0.704
Hematotoxicity:  0.548 Drug-induced Nephrotoxicity:  0.926
Genotoxicity:  0.329 RPMI-8226 Immunitoxicity:  0.239
A549 Cytotoxicity:  0.64 Hek293 Cytotoxicity:  0.76
BCF:   1.491
?
Bioconcentration factors are used for considering secondary poisoning potential and assessing risks to human health via the food chain. The unit is -log10[(mg/L)/(1000*MW)].
IGC50:   5.287
?
48 hour Tetrahymena pyriformis IGC50. The unit of IGC50 is -log10[(mg/L)/(1000*MW)].
LC50DM:   6.566
?
48 hour Daphnia magna LC50. The unit of LC50DM is -log10[(mg/L)/(1000*MW)].
LC50FM:   6.39
?
96 hour fathead minnow LC50. The unit of LC50FM is -log10[(mg/L)/(1000*MW)].

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO19367 Thespesia populnea Species Malvaceae Eukaryota n.a. n.a. n.a. PMID[18553924]
NPO19367 Thespesia populnea Species Malvaceae Eukaryota n.a. n.a. n.a. Database[COCONUT]
NPO19367 Thespesia populnea Species Malvaceae Eukaryota n.a. n.a. n.a. Database[HerDing]
NPO19367 Thespesia populnea Species Malvaceae Eukaryota n.a. n.a. n.a. Database[TCMID]
NPO19367 Thespesia populnea Species Malvaceae Eukaryota n.a. n.a. n.a. Database[UNPD]

Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].



  NP Quantity Composition/Concentration

Organism ID Organism Name Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].



 Biological Activity

Molecular-level activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT41 Individual protein Aldose reductase Homo sapiens Ki = 1500.0 nM PMID[24900794]

In vitro activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT83 Cell line MCF7 Homo sapiens IC50 = 4.0 ug.mL-1 DOI[10.6019/CHEMBL1201861]
NPT165 Cell line HeLa Homo sapiens IC50 > 5.0 ug.mL-1 PMID[23350733]
NPT139 Cell line HT-29 Homo sapiens IC50 = 3.0 ug.mL-1 PMID[22824205]
NPT91 Cell line KB Homo sapiens IC50 > 5.0 ug.mL-1 PMID[22552195]
NPT368 Cell line SN12C Homo sapiens GI50 n.a. 2735.27 nM DOI[10.1039/C3MD00166K]
NPT370 Cell line NCI-H23 Homo sapiens GI50 n.a. 3614.1 nM PMID[17958396]
NPT371 Cell line UO-31 Homo sapiens GI50 n.a. 3303.7 nM PMID[25479041]
NPT369 Cell line ACHN Homo sapiens GI50 n.a. 2426.61 nM PMID[15217268]
NPT116 Cell line HL-60 Homo sapiens GI50 n.a. 4456.56 nM PMID[22037378]
NPT372 Cell line HOP-92 Homo sapiens GI50 n.a. 2197.86 nM PMID[25397992]
NPT374 Cell line SF-539 Homo sapiens GI50 n.a. 4355.12 nM DrugMatrix in vivo data: Pathology
NPT375 Cell line Malme-3M Homo sapiens GI50 n.a. 5754.4 nM PMID[18247546]
NPT373 Cell line SK-MEL-5 Homo sapiens GI50 n.a. 9225.71 nM PMID[20713679]
NPT111 Cell line K562 Homo sapiens GI50 n.a. 11776.06 nM PMID[20151678]
NPT377 Cell line OVCAR-3 Homo sapiens GI50 n.a. 3365.12 nM PMID[19733087]
NPT376 Cell line A498 Homo sapiens GI50 n.a. 11402.5 nM Open TG-GATES in vivo data: Hematology
NPT112 Cell line MOLT-4 Homo sapiens GI50 n.a. 7533.56 nM DOI[10.1584/jpestics.27.127]
NPT379 Cell line HOP-62 Homo sapiens GI50 n.a. 2978.52 nM PMID[19015352]
NPT380 Cell line U-251 Homo sapiens GI50 n.a. 3198.9 nM PMID[19604701]
NPT382 Cell line OVCAR-5 Homo sapiens GI50 n.a. 7079.46 nM PMID[19813743]
NPT381 Cell line OVCAR-8 Homo sapiens GI50 n.a. 3741.11 nM DrugMatrix in vivo data: Pathology
NPT383 Cell line SNB-19 Homo sapiens GI50 n.a. 3881.5 nM DOI[10.6019/CHEMBL1201861]
NPT572 Cell line DMS-273 Homo sapiens GI50 n.a. 5105.05 nM PMID[20430633]
NPT385 Cell line SR Homo sapiens GI50 n.a. 4395.42 nM PMID[24224794]
NPT384 Cell line TK-10 Homo sapiens GI50 n.a. 6714.29 nM PMID[15646539]
NPT323 Cell line SW-620 Homo sapiens GI50 n.a. 5333.35 nM PMID[25725608]
NPT573 Cell line M19-MEL Homo sapiens GI50 n.a. 3647.54 nM PMID[24973030]
NPT455 Cell line NCI-H522 Homo sapiens GI50 n.a. 2624.22 nM PMID[17958396]
NPT574 Cell line XF498 Homo sapiens GI50 n.a. 3732.5 nM PMID[20055495]
NPT387 Cell line M14 Homo sapiens GI50 n.a. 9862.79 nM PMID[25397992]
NPT386 Cell line KM12 Homo sapiens GI50 n.a. 5046.61 nM PMID[17850214]
NPT389 Cell line RPMI-8226 Homo sapiens GI50 n.a. 4315.19 nM PMID[25978960]
NPT388 Cell line NCI-H322M Homo sapiens GI50 n.a. 5321.08 nM DrugMatrix in vitro pharmacology data
NPT456 Cell line OVCAR-4 Homo sapiens GI50 n.a. 3863.67 nM PubChem BioAssay data set
NPT147 Cell line SK-MEL-2 Homo sapiens GI50 n.a. 4446.31 nM PMID[19914074]
NPT81 Cell line A549 Homo sapiens GI50 n.a. 3523.71 nM PMID[12747798]
NPT575 Cell line KM-20L2 Homo sapiens GI50 n.a. 6011.74 nM PMID[18936192]
NPT391 Cell line HCC 2998 Homo sapiens GI50 n.a. 2654.61 nM PubChem BioAssay data set
NPT392 Cell line SNB-75 Homo sapiens GI50 n.a. 2404.36 nM PMID[23398362]
NPT148 Cell line HCT-15 Homo sapiens GI50 n.a. 3741.11 nM PMID[21123165]
NPT395 Cell line SF-268 Homo sapiens GI50 n.a. 5714.79 nM DOI[10.6019/CHEMBL3301361]
NPT393 Cell line HCT-116 Homo sapiens GI50 n.a. 2606.15 nM PMID[20638854]
NPT394 Cell line EKVX Homo sapiens GI50 n.a. 4864.07 nM PMID[25136754]
NPT731 Cell line LXFL 529 Homo sapiens GI50 n.a. 3962.78 nM PMID[25647077]
NPT576 Cell line DMS-114 Homo sapiens GI50 n.a. 3076.1 nM PMID[20231393]
NPT146 Cell line SK-OV-3 Homo sapiens GI50 n.a. 4187.94 nM PMID[20815366]
NPT397 Cell line NCI-H460 Homo sapiens GI50 n.a. 4720.63 nM PMID[7131486]
NPT398 Cell line UACC-62 Homo sapiens GI50 n.a. 11912.42 nM PMID[21458279]
NPT308 Cell line CAKI-1 Homo sapiens GI50 n.a. 6081.35 nM PMID[9514009]
NPT399 Cell line SF-295 Homo sapiens GI50 n.a. 4187.94 nM DrugMatrix in vitro pharmacology data
NPT458 Cell line IGROV-1 Homo sapiens GI50 n.a. 5470.16 nM DOI[10.6019/CHEMBL1201861]
NPT403 Cell line UACC-257 Homo sapiens GI50 n.a. 10914.4 nM PMID[9207945]
NPT578 Cell line SNB-78 Homo sapiens GI50 n.a. 25292.98 nM PMID[23107479]
NPT404 Cell line CCRF-CEM Homo sapiens GI50 n.a. 5164.16 nM PMID[19273668]
NPT579 Cell line DLD-1 Homo sapiens GI50 n.a. 4375.22 nM PMID[25211032]
NPT405 Cell line NCI-H226 Homo sapiens GI50 n.a. 2426.61 nM PubChem BioAssay data set
NPT139 Cell line HT-29 Homo sapiens GI50 n.a. 4130.48 nM DOI[10.6019/CHEMBL1201861]
NPT170 Cell line SK-MEL-28 Homo sapiens GI50 n.a. 6606.93 nM PMID[12828470]
NPT406 Cell line RXF 393 Homo sapiens GI50 n.a. 2523.48 nM PubChem BioAssay data set
NPT407 Cell line COLO 205 Homo sapiens GI50 n.a. 1887.99 nM PMID[18160520]
NPT79 Organism Bacillus subtilis Bacillus subtilis MIC = 2.34 ug.mL-1 PMID[17850214]
NPT16 Organism Staphylococcus aureus Staphylococcus aureus MIC = 4.69 ug.mL-1 Open TG-GATES in vivo data: Biochemistry
NPT175 Organism Enterococcus faecalis Enterococcus faecalis MIC = 1.17 ug.mL-1 DOI[10.6019/CHEMBL1201861]

In vivo activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference





 Experimental ADME

Experiment Model Experiment Tissue ADME Type ADME Relation ADME Value ADME Unit Reference





 Experimental Toxicity

Quantitative toxicity

Experiment Model Experiment Organism Toxicity Type Toxicity Relation Toxicity Value Toxicity Unit Reference

Common Abbreviations:
LC: Lethal Concentration; LD: Lethal Dose; LT:Lethal Time; NOAEL: No-observed-adverse-effect Level; BMDL: Benchmark Dose Lower Confidence Limit; BMD: Benchmark Dose; BMC:Benchmark Concentration; LOAEL: Lowest Observed Adverse Effect Level; RfD:Reference Dose; RfC:Reference Concentration; MRL: Minimal Risk Level; MEG: Maximum Exposure Guideline; PAC: Protective Action Criteria

Categorical toxicity labels

Hepatotoxicity Carcinogenicity Mutagenicity Cardiotoxicity Respiratory Toxicity Eye Irritation Endocrine Disruption
Hepatotoxicity Carcinogenicity Mutagenicity Cardiotoxicity Respiratory Toxicity Eye Irritation Endocrine Disruption

Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP toxicity records from domain-specific databases. These databases include:
ToxValDB: a curated database that compiles quantitative toxicity values for chemicals from diverse public sources to support toxicological research and risk assessment.
TOXRIC: a comprehensive, free-to-access, online database providing toxicological/feature data. The toxicity labels are retrieved from this database. [PMID: 36400569]


  Chemically structural similarity

Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes approximately 50,000 NPs with experimentally-derived bioactivity available in NPASS)

Similarity is measured using the Tanimoto coefficient (Tc) , which compares the binary fingerprints of two molecules. Tc is calculated as the intersection divided by the union of '1' bits in the fingerprints, ranging from 0 to 1, with 1 indicating highest similarity.

●  The left chart: Distribution of similarity level between NPC141574 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.5 or Top200).

Similarity Score Similarity Level Natural Product ID
0.6042 Remote Similarity NPC68441

Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC141574 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.5 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
0.6042 Remote Similarity NPD7422 Phase 3

Bioactivity similarity

  Bioactivity similarity

Similar Natural Products in NPASS

Similarity level is defined by Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.
Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data